The Role of Quantitative Pathology in Clinical Decision Making for Barrett’s Oesophagus

por Polkowski, Wojciech, van Lanschot, J. Jan B., van Sandick, Johanna W., Baak, Jan P.A.
Publicado 2003

The effectivity of targeted therapy and immunotherapy in patients with advanced metastatic and non-metastatic cancer of the esophagus and esophago-gastric junction

por Valkema, M. J., Mostert, B., Lagarde, S. M., Wijnhoven, B. P. L., van Lanschot, J. J. B.
Publicado 2022

Fixed Size of Enlarged Calcified Lymph Nodes in Esophageal Adenocarcinoma despite Complete Remission

por Grotenhuis, B.A., Wijnhoven, B.P.L., Hermans, J.J., Biermann, K., van Lanschot, J.J.B.
Publicado 2009

Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma

por Tuynman, J B, Lagarde, S M, ten Kate, F J W, Richel, D J, van Lanschot, J J B
Publicado 2008

Patients’ Preferences for Surgical Management of Esophageal Cancer: A Discrete Choice Experiment

por de Bekker-Grob, Esther W., Niers, Eva J., van Lanschot, J. Jan B., Steyerberg, Ewout W., Wijnhoven, Bas P. L.
Publicado 2015

Radiological evaluation of colorectal anastomoses

por Doeksen, A., Tanis, P. J., Wüst, A. F. J., Vrouenraets, B. C., van Lanschot, J. J. B., van Tets, W. F.
Publicado 2008

FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review

por Omloo, J. M. T., van Heijl, M., Hoekstra, O. S., van Berge Henegouwen, M. I., van Lanschot, J. J. B., Sloof, G. W.
Publicado 2011

Sarcopenia/Muscle Mass is not a Prognostic Factor for Short- and Long-Term Outcome After Esophagectomy for Cancer

por Grotenhuis, Brechtje A., Shapiro, Joël, van Adrichem, Stefan, de Vries, Marianne, Koek, Marcel, Wijnhoven, Bas P. L., van Lanschot, J. Jan B.
Publicado 2016

Prognostic Value of Body Mass Index on Short-Term and Long-Term Outcome after Resection of Esophageal Cancer

por Grotenhuis, B. A., Wijnhoven, B. P. L., Hötte, G. J., van der Stok, E. P., Tilanus, H. W., van Lanschot, J. J. B.
Publicado 2010

Sexual and urinary functioning after rectal surgery: a prospective comparative study with a median follow-up of 8.5 years

por Doeksen, Annemiek, Gooszen, Jan A. H., van Duijvendijk, Peter, Tanis, Pieter J., Bakx, Roel, Slors, J. Frederik M., van Lanschot, J. Jan B.
Publicado 2011

Interventions that Facilitate Shared Decision-Making in Cancers with Active Surveillance as Treatment Option: a Systematic Review of Literature

por Collée, G. E., van der Wilk, B. J., van Lanschot, J. J. B., Busschbach, J. J., Timmermans, L., Lagarde, S. M., Kranenburg, L. W.
Publicado 2020

External Validation of Pretreatment Pathological Tumor Extent in Patients with Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer

por Brinkmann, Sebastian, Noordman, Bo J., Hölscher, Arnulf H., Biermann, Katharina, van Klaveren, David, Bollschweiler, Elfriede, Pütz, Katharina, van Lanschot, J. Jan B., Drebber, Uta
Publicado 2019

Early onset esophageal adenocarcinoma: a distinct molecular entity?

por van Nistelrooij, Anna M.J., van Marion, Ronald, Biermann, Katharina, Spaander, Manon C.W., van Lanschot, J. Jan B., Wijnhoven, Bas P.L., Dinjens, Winand N.M.
Publicado 2016

Oesophageal cancer: exploring controversies overview of experts’ opinions of Austria, Germany, France, Netherlands and Switzerland

por Putora, Paul Martin, Bedenne, Laurent, Budach, Wilfried, Eisterer, Wolfgang, Van Der Gaast, Ate, Jäger, Robert, Van Lanschot, J. Jan B., Mariette, Christophe, Schnider, Annelies, Stahl, Michael, Ruhstaller, Thomas
Publicado 2015

Patients’ perception of diagnostic tests in the preoperative assessment of esophageal cancer

por Westerterp, Marinke, van Westreenen, Henderik L, Deutekom, Marije, Stoker, Jaap, Fockens, Paul, Comans, Emile FI, Plukker, John TM, Bossuyt, Patrick MM, van Lanschot, J Jan B, Sloof, Gerrit W
Publicado 2008

Loss of SRY‐box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma

por ten Kate, F. J. C., van Olphen, S. H., Bruno, M. J., Wijnhoven, B. P. L., van Lanschot, J. J. B., Looijenga, L. H. J., Fitzgerald, R. C., Biermann, K.
Publicado 2017

Characteristics Predicting Short-Term and Long-Term Health-Related Quality of Life in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy and Esophagectomy

por van der Wilk, Berend J., Eyck, Ben M., Noordman, Bo J., Kranenburg, Leonieke W., Oppe, Mark, Lagarde, Sjoerd M., Wijnhoven, Bas P. L., Busschbach, Jan J., van Lanschot, J. Jan B.
Publicado 2023

Pattern of recurrence in patients with a pathologically complete response after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer

por de Jongh, M, Eyck, B M, van der Werf, L R, Toxopeus, E L A, van Lanschot, J J B, Lagarde, S M, van der Gaast, A, Nuyttens, J, Wijnhoven, B P L
Publicado 2021

Transhiatal vs extended transthoracic resection in oesophageal carcinoma: patients' utilities and treatment preferences

por de Boer, A G E M, Stalmeier, P F M, Sprangers, M A G, de Haes, J C J M, van Sandick, J W, Hulscher, J B F, van Lanschot, J J B
Publicado 2002

Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples

por van Nistelrooij, Anna M. J., van Marion, Ronald, Koppert, Linetta B., Biermann, Katharina, Spaander, Manon C. W., Tilanus, Hugo W., van Lanschot, J. Jan B., Wijnhoven, Bas P. L., Dinjens, Winand N. M.
Publicado 2017